Detection of Anti-SARS-CoV-2 Nucleocapsid and Spike Antibodies in Patients with Coronavirus Disease 2019 in Japan.
Hiroshi FurukawaShomi OkaTakashi HiguchiMiho YamaguchiShota UchiyamaTomohiro KoiwaMoriyuki NakamaMasaaki MinegishiHideaki NagaiShigeto TohmaPublished in: Clinical medicine insights. Circulatory, respiratory and pulmonary medicine (2022)
To increase the sensitivity of serological diagnostic tests for COVID-19, it is suggested that both anti-SARS-CoV-2 N and S Abs should be measured and cut-off levels decreased.